Edesa Biotech Adds Mechanically Ventilated Patients to Phase 3 ARDS Study

Go back to Edesa Biotech Adds Mechanically Ventilated Patients to Phase 3 ARDS Study
(NASDAQ: EDSA) Delayed: 4.97 --0 (-0%)
Previous Close $4.97    52 Week High
Open $4.97    52 Week Low
Day High $4.97    P/E N/A 
Day Low $4.97    EPS
Volume 55